USMEF Statement on Study Confirming Effectiveness of Export Market Development Programs

May 23, 2022

On May 18, the U.S. Agricultural Export Development Council (USAEDC) released an economic impact study confirming the effectiveness of export market development programs in expanding demand for U.S. agricultural products and generating a strong return on investment. The study was commissioned by the U.S. Grains Council on behalf of USAEDC members. More details are also available in this USAEDC press release and infographic.

USMEF President and CEO Dan Halstrom issued this statement:

The remarkable rate of growth for U.S. red meat exports would not have been possible without critical investments available through the USDA Market Access Program and Foreign Market Development Program. More recently, the Agricultural Trade Promotion Program also helped offset the impact of retaliatory measures imposed by some trading partners. The USAEDC study quantifies the effectiveness of these programs and confirms the positive impact these investments have on the bottom line of U.S. farmers and ranchers and everyone in the U.S. supply chain. USMEF thanks USAEDC and the U.S. Grains Council for organizing the study and for making this information available to policy makers and key stakeholders.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.